Okay, let's tackle this question about the duration of treatment for multibacillary and paucibacillary leprosy. First, I need to recall the WHO guidelines for leprosy treatment. From what I remember, leprosy is managed with multidrug therapy (MDT), and the duration varies based on whether the case is multibacillary or paucibacillary.

Multibacillary leprosy, which has a higher bacterial load, typically requires a longer treatment course. I think it's 12 months. Paucibacillary, with fewer bacilli, is shorter, maybe 6 months. The drugs involved are dapsone, rifampicin, and clofazimine. For multibacillary, the regimen includes all three drugs, while paucibacillary uses dapsone and rifampicin but not clofazimine.

Wait, let me double-check. WHO's MDT for multibacillary is indeed 12 months with dapsone (100 mg), rifampicin (600 mg), and clofazimine (300 mg monthly). Paucibacillary is 6 months with dapsone (100 mg) and rifampicin (600 mg monthly). So the correct answer would be 12 months for multibacillary and 6 months for paucibacillary. The options might be presented as A to D with different combinations. The other options could mix up the durations or include incorrect drug combinations. For example, someone might confuse the duration with the number of skin lesions required for classification, but the key point is the treatment length. Also, some options might use different months or include drugs not part of the standard MDT. So the correct answer is the one that states 12 months for multibacillary and 6 months for paucibacillary.

**Core Concept**
Leprosy treatment duration depends on bacillary load, classified as multibacillary (MB) or paucibacillary (PB). The World Health Organization (WHO) recommends multidrug therapy (MDT) with specific durations for each type to ensure effective eradication of *Mycobacterium leprae* and prevent drug resistance.

**Why the Correct Answer is Right**
Multibacillary leprosy (≥5 skin lesions, positive bacilloscopy) requires **12 months** of MDT: dapsone (100 mg/d), rifampicin (600 mg/mo), and clofazimine (300 mg/mo). Paucibacillary leprosy (≤5 lesions, negative bacilloscopy) is treated for **6 months** with dapsone (100 mg/d) and rifampicin (600 mg/mo). This duration targets the slower replication of *M. leprae* and prevents relapse. Clofazimine is omitted in PB leprosy due to its role in reducing bacterial load in MB cases only.

**Why Each Wrong Option is Incorrect**
**Option A:** May suggest 6 months for both types—incorrect, as MB requires longer therapy to address higher bacillary load.
**Option B:** Could propose 12 months for PB—unw

✓ Correct Answer: C. 12 months and 6 months